ArticleJournal of gastrointestinal oncology2026
Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single-center study.
Soetkin D'Haens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.